Prevalence of Elevated Insulin Resistance Risk in a Large Office Worker Population: Sex-Stratified Analyses and Lifestyle Correlates
Abstract
1. Introduction
2. Methods
2.1. Study Design and Population
2.1.1. Inclusion Criteria
- Age between 18 and 69 years.
- Active employment status during the study period.
- Occupation classified as sedentary (i.e., office-based).
- Availability of complete data on anthropometric, biochemical, sociodemographic, and lifestyle variables.
2.1.2. Exclusion Criteria
- Missing data on fasting glucose or triglycerides.
- Incomplete records for anthropometric measurements (e.g., weight, height, waist circumference).
- Missing responses on physical activity, smoking, or dietary questionnaires.
- Diagnosed type 1 or type 2 diabetes mellitus.
- Extreme values or biologically implausible measurements. Extreme values were defined as observations lying beyond ±4 standard deviations from the mean for continuous variables. These values were excluded as probable data entry or measurement errors.
- Individuals with diagnosed diabetes were excluded because their lifestyle behaviors may have already been modified by medical advice, which could confound associations. We acknowledge that this exclusion may lead to underestimation of the true prevalence of IR in office workers.
2.2. Anthropometric and Clinical Measurements
2.3. Insulin Resistance Indices
- TyG index = ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2].
- METS-IR = ln [(2 × fasting glucose) + triglycerides] × BMI / ln [HDL cholesterol].
2.4. Lifestyle and Sociodemographic Variables
- Smoking status was categorized as current, former, or never smoker.
- Physical activity was assessed using the short version of the International Physical Activity Questionnaire (IPAQ-SF). Participants were classified as physically active if they reported ≥150 min/week of moderate activity, ≥75 min/week of vigorous activity, or an equivalent combination [32].
- Physical activity was assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF), validated in Spanish adult populations [33]. Diet quality was evaluated with the 14-item Mediterranean Diet Adherence Screener (MEDAS), validated in Spanish cohorts [34]. Although not specifically tested in office workers, these instruments have shown reliability in occupational health contexts.
- Adherence to the Mediterranean diet was measured using a validated short screener; scores ≥ 9 indicated good adherence to the dietary pattern [35].
- Lifestyle factors were evaluated using validated tools: physical activity with the IPAQ-SF and dietary habits with the 14-item Mediterranean diet screener (MEDAS), both previously validated in Spanish populations. Smoking status was obtained through a standardized occupational health questionnaire. To minimize recall and social desirability biases, all questionnaires were administered during routine occupational health assessments under uniform conditions, with guarantees of anonymity and confidentiality to limit reporting bias.
2.5. Statistical Analysis
3. Results
4. Discussion
4.1. Comparison with Previous Studies
4.2. Main Contributions of This Study
- This study represents one of the largest analyses to date focusing exclusively on office workers, adding valuable evidence to the field.
- Use of validated, non-insulin-based indices: By employing TyG, METS-IR, and SPISE, we provide a feasible, cost-effective alternative to direct insulin measurements, which are rarely included in occupational screening protocols.
- Comprehensive lifestyle analysis: Our inclusion of physical activity (measured by IPAQ), smoking status, and adherence to the Mediterranean diet allows for a more nuanced understanding of behavioral determinants of IR.
- Analytical depth: We present detailed multivariate logistic regression models stratified by sex, adjusting for key sociodemographic and lifestyle factors, enhancing the robustness and clinical relevance of our findings.
- Furthermore, the robustness of our results was supported by sensitivity analyses stratified by age ranges, which yielded consistent associations across all subgroups. This reinforces the reliability of our findings and suggests that the observed patterns are not driven by specific age categories within the office-working population.
4.3. Strengths and Limitations
- Large, homogeneous sample size of over 82,000 office workers, which enhances statistical power and generalizability to similar occupational environments.
- Standardized data collection by trained personnel following rigorous clinical protocols.
- Application of multiple IR indices, allowing comparison of their predictive performance in a real-world occupational setting.
- Stratification by sex and lifestyle, which reduces confounding and highlights high-risk subgroups for targeted interventions.
- Given the cross-sectional design, temporality cannot be established, and reverse causation (e.g., individuals with elevated IR risk being less active) cannot be excluded. Longitudinal studies are needed to confirm causal pathways.
- Although validated, the surrogate indices used (TyG, METS-IR, SPISE) may not fully reflect dynamic metabolic processes captured by gold-standard techniques such as the euglycemic clamp.
- Although validated questionnaires and standardized protocols were applied, self-reported lifestyle factors are inherently prone to recall and social desirability bias, which may have led to some degree of misclassification.
- Additionally, individuals with diagnosed diabetes were excluded from the analyses. This decision was made to avoid potential bias arising from lifestyle modifications following medical advice, which could distort associations with IR indices. However, this exclusion may also result in underestimation of the true prevalence of insulin resistance among office workers.
- Our sample was limited to Spanish office workers, predominantly from a homogeneous European background. Extrapolation to more ethnically diverse populations, those with different occupational structures, or workers in lower-income settings should be done cautiously.
- Although the thresholds used to classify elevated IR risk are based on widely cited validation studies [13,25,26,31], it is important to acknowledge that specific validation in occupational cohorts remains limited. The use of these indices should therefore be interpreted as a pragmatic approach to estimate IR risk in large populations of office workers rather than as definitive diagnostic criteria. Future research should focus on establishing tailored cutoffs that account for occupational and demographic characteristics.
- Another limitation of our study is the absence of data on certain lifestyle and psychosocial factors that may act as potential confounders. Specifically, alcohol consumption, psychological stress, and sleep duration/quality were not available in our dataset. Each of these factors has been consistently associated with insulin resistance and metabolic dysfunction in previous studies [70]. For example, moderate-to-high alcohol intake has been linked to impaired insulin signaling and increased risk of type 2 diabetes, while chronic stress may contribute to hypercortisolism and systemic inflammation, both of which exacerbate insulin resistance. Similarly, short or disrupted sleep has been identified as an independent determinant of insulin resistance through mechanisms involving altered glucose metabolism, sympathetic activation, and hormonal dysregulation. The absence of these variables in our analyses may therefore contribute to residual confounding and partially explain the strength of some associations observed. Future studies in occupational cohorts should incorporate comprehensive assessments of alcohol intake, stress, and sleep to more accurately capture the multifactorial determinants of insulin resistance.
- Finally, a potential healthy worker bias should be acknowledged, as employed individuals undergoing occupational health assessments may represent a healthier subset compared to the general population, possibly underestimating true IR prevalence.
4.4. Implications and Future Directions
- Validate these indices prospectively, tracking their ability to predict incident diabetes, cardiovascular disease, and mortality in diverse occupational cohorts.
- Investigate interventional strategies targeting modifiable risk factors (diet, smoking, physical inactivity) to assess whether improvements in TyG, METS-IR, and SPISE translate to clinical benefit.
- Explore the integration of digital health tools (e.g., wearables, mobile apps) for continuous lifestyle tracking and personalized feedback.
- Conduct cost-effectiveness analyses comparing these indices with traditional diagnostic approaches in occupational medicine settings.
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Ethical Approval and Regulatory Compliance
References
- Kosmas, C.E.; Bousvarou, M.D.; Kostara, C.E.; Papakonstantinou, E.J.; Salamou, E.; Guzman, E. Insulin resistance and cardiovascular disease. J. Int. Med. Res. 2023, 51, 03000605231164548. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Adams-Huet, B.; Zubirán, R.; Remaley, A.T.; Jialal, I. The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States. J. Clin. Lipidol. 2024, 18, e518–e524. [Google Scholar] [CrossRef] [PubMed]
- Wu, C.; Ke, Y.; Nianogo, R.A. Trends in Hyperinsulinemia and Insulin Resistance Among Nondiabetic US Adults, NHANES, 1999–2018. J. Clin. Med. 2025, 14, 3215. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Aguiló Juanola, M.C.; López-González, A.A.; Tomás-Gil, P.; Paublini, H.; Tárraga-López, P.J.; Ramírez-Manent, J.I. Influence of tobacco consumption on the values of different insulin resistance risk scales and non-alcoholic fatty liver disease and hepatic fibrosis scales in 418,343 spanish people. Acad. J. Health Sci. 2024, 39, 9–15. [Google Scholar] [CrossRef]
- Freeman, A.M.; Acevedo, L.A.; Pennings, N. Insulin Resistance. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2025. [Google Scholar] [PubMed]
- Gubbi, S.; Muniyappa, R.; Sharma, S.T.; Grewal, S.; McGlotten, R.; Nieman, L.K. Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals. J. Clin. Endocrinol. Metab. 2021, 106, 1501–1515. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Paracha, A.I.; Haroon, Z.H.; Aamir, M.; Bibi, A. Diagnostic Accuracy of Markers of Insulin Resistance (HOMA-IR) and Insulin Sensitivity (QUICKI) in Gestational Diabetes. J. Coll. Physicians Surg. Pak. 2021, 31, 1015–1019. [Google Scholar] [CrossRef] [PubMed]
- Sastre-Alzamora, T.; Tomás-Gil, P.; Paublini, H.; Pallarés, L.; Ramírez-Manent, J.I.; López-González, A.A. Relationship between heart age and insulin resistance risk scales in 139634 Spanish workers. Acad. J. Health Sci. 2024, 39, 16–22. [Google Scholar] [CrossRef]
- Ramdas Nayak, V.K.; Satheesh, P.; Shenoy, M.T.; Kalra, S. Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance. J. Pak. Med. Assoc. 2022, 72, 986–988. [Google Scholar] [CrossRef] [PubMed]
- Nayak, S.S.; Kuriyakose, D.; Polisetty, L.D.; Patil, A.A.; Ameen, D.; Bonu, R.; Shetty, S.P.; Biswas, P.; Ulrich, M.T.; Letafatkar, N.; et al. Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis. Cardiovasc. Diabetol. 2024, 23, 310. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Vicente-Herrero, M.T.; Egea-Sancho, M.; Ramírez Iñiguez de la Torre, M.V.; López-González, A.A. Relación de los índices de adiposidad visceral (VAI) y adiposidad disfuncional (DAI) con las escalas de riesgo de resistencia a la insulina y prediabetes. Acad. J. Health Sci. 2024, 39, 25–31. [Google Scholar] [CrossRef]
- Peng, H.; Xiang, J.; Pan, L.; Zhao, M.; Chen, B.; Huang, S.; Yao, Z.; Liu, J.; Lv, W. METS-IR/HOMA-IR and MAFLD in U.S. adults: Dose–response correlation and the effect mediated by physical activity. BMC Endocr. Disord. 2024, 24, 132. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tantari, G.; Bassi, M.; Pistorio, A.; Minuto, N.; Napoli, F.; Piccolo, G.; La Valle, A.; Spacco, G.; Cervello, C.; D’annunzio, G.; et al. SPISE INDEX (Single point insulin sensitivity estimator): Indicator of insulin resistance in children and adolescents with overweight and obesity. Front. Endocrinol. 2024, 15, 1439901. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Vicente-Herrero, M.T.; Gordito Soler, M.; García Agudo, S.; Vallejos, D.; López-González, A.A.; Ramírez-Manent, J.I. Cardiometabolic risk level in 1136 Spanish professional musicians. Acad. J. Health Sci. 2024, 39, 59–66. [Google Scholar] [CrossRef]
- Zhou, H.; Ding, X.; Lan, Y.; Chen, S.; Wu, S.; Wu, D. Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: A cohort study. Cardiovasc. Diabetol. 2023, 22, 341. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Teymoori, F.; Jahromi, M.K.; Ahmadirad, H.; Daftari, G.; Mokhtari, E.; Farhadnejad, H.; Mirmiran, P.; Azizi, F. The association of dietary and lifestyle indices for insulin resistance with the risk of cardiometabolic diseases among Iranian adults. Sci. Rep. 2023, 13, 6224. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tian, X.; Zuo, Y.; Chen, S.; Meng, X.; Chen, P.; Wang, Y.; Wu, S.; Luo, Y.; Wang, A. Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults. Am. Heart J. 2022, 248, 63–71. [Google Scholar] [CrossRef] [PubMed]
- Sangouni, A.A.; Hosseinzadeh, M.; Parastouei, K. Effect of dietary approaches to stop hypertension diet on insulin resistance and lipid accumulation product in subjects with metabolic syndrome. Sci. Rep. 2025, 15, 17025. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ciarambino, T.; Crispino, P.; Guarisco, G.; Giordano, M. Gender Differences in Insulin Resistance: New Knowledge and Perspectives. Curr. Issues Mol. Biol. 2023, 45, 7845–7861. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ryde, G.C.; Brown, H.E.; Gilson, N.D.; Brown, W.J. Are we chained to our desks? Describing desk-based sitting using a novel measure of occupational sitting. J. Phys. Act. Health 2014, 11, 1318–1323. [Google Scholar] [CrossRef] [PubMed]
- Gómez-Recasens, M.; Alfaro-Barrio, S.; Tarro, L.; Llauradó, E.; Solà, R. Occupational Physical Activity and Cardiometabolic Risk Factors: A Cross-Sectional Study. Nutrients 2023, 15, 1421. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Cederholm, J.; Zethelius, B. SPISE and other fasting indexes of insulin resistance: Risks of coronary heart disease or type 2 diabetes. Comparative cross-sectional and longitudinal aspects. Upsala J. Med. Sci. 2019, 124, 265–272. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Correa-Burrows, P.; Matamoros, M.; de Toro, V.; Zepeda, D.; Arriaza, M.; Burrows, R. A Single-Point Insulin Sensitivity Estimator (SPISE) of 5.4 is a good predictor of both metabolic syndrome and insulin resistance in adolescents with obesity. Front. Endocrinol. 2023, 14, 1078949. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Manzanero, R.Z.; López-González, A.A.; Tomás-Gil, P.; Paublini, H.; Martínez-Jover, A.; Ramírez-Manent, J.I. Cardiometabolic risk assessment in 28300 spanish waiters. Acad. J. Health Sci. 2023, 39, 16–24. [Google Scholar] [CrossRef]
- Guerrero-Romero, F.; Simental-Mendía, L.E.; Gonzalez-Ortiz, M.; Martínez-Abundis, E.; Ramos-Zavala, M.G.; Hernandez-Gonzalez, S.O.; Jacques-Camarena, O.; Rodríguez-Moran, M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 2010, 95, 3347–3351. [Google Scholar] [CrossRef] [PubMed]
- Lee, Y.C.; Lee, J.W.; Kwon, Y.J. Comparison of the triglyceride glucose (TyG) index, triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, and metabolic score for insulin resistance (METS-IR) associated with periodontitis in Korean adults. Ther. Adv. Chronic Dis. 2022, 13, 20406223221122671. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- D’Elia, L.; Rendina, D.; Iacone, R.; Strazzullo, P.; Galletti, F. Triglyceride–Glucose Index and New-Onset Type 2 Diabetes Mellitus in Middle-Aged Men. Metabolites 2025, 15, 537. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Paulmichl, K.; Hatunic, M.; Højlund, K.; Jotic, A.; Krebs, M.; Mitrakou, A.; Porcellati, F.; Tura, A.; Bergsten, P.; Forslund, A.; et al. Modification and Validation of the Triglyceride-to-HDL Cholesterol Ratio as a Surrogate of Insulin Sensitivity in White Juveniles and Adults without Diabetes Mellitus: The Single Point Insulin Sensitivity Estimator (SPISE). Clin. Chem. 2016, 62, 1211–1219. [Google Scholar] [CrossRef] [PubMed]
- Bello-Chavolla, O.Y.; Almeda-Valdes, P.; Gomez-Velasco, D.; Viveros-Ruiz, T.; Cruz-Bautista, I.; Romo-Romo, A.; Sánchez-Lázaro, D.; Meza-Oviedo, D.; Vargas-Vázquez, A.; Campos, O.A.; et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur. J. Endocrinol. 2018, 178, 533–544. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Hui, X.; Huang, X.; Li, J.; Liu, N. Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification. BMC Endocr. Disord. 2022, 22, 274. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Sánchez-Íñigo, L.; Navarro-González, D.; Fernández-Montero, A.; Pastrana-Delgado, J.; Martínez, J.A. The TyG index may predict the development of cardiovascular events. Eur. J. Clin. Investig. 2016, 46, 189–197. [Google Scholar] [CrossRef] [PubMed]
- Meh, K.; Jurak, G.; Sorić, M.; Rocha, P.; Sember, V. Validity and Reliability of IPAQ-SF and GPAQ for Assessing Sedentary Behaviour in Adults in the European Union: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2021, 18, 4602. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Román Viñas, B.; Ribas Barba, L.; Ngo, J.; Serra Majem, L. Validación en población catalana del cuestionario internacional de actividad física [Validity of the international physical activity questionnaire in the Catalan population (Spain)]. Gac. Sanit. 2013, 27, 254–257. (In Spanish) [Google Scholar] [CrossRef] [PubMed]
- Schröder, H.; Fitó, M.; Estruch, R.; Martínez-González, M.A.; Corella, D.; Salas-Salvadó, J.; Lamuela-Raventós, R.; Ros, E.; Salaverría, I.; Fiol, M.; et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J. Nutr. 2011, 141, 1140–1145. [Google Scholar] [CrossRef] [PubMed]
- Mestre Font, M.; Busquets-Cortés, C.; Ramírez-Manent, J.I.; Vallejos, D.; Sastre Alzamora, T.; López-González, A.A. Influence of sociodemographic variables and healthy habits on the values of cardiometabolic risk scales in 386.924 spanish workers. Acad. J. Health Sci. 2024, 39, 112–121. [Google Scholar] [CrossRef]
- Tosoratto, J.; Carriedo, B.; Cantón, C. Cardiometabolic risk level in 43.074 Spanish office workers: Associated variables. Acad. J. Health Sci. 2024, 39, 48–56. [Google Scholar] [CrossRef]
- Liu, X.; Tan, Z.; Huang, Y.; Zhao, H.; Liu, M.; Yu, P.; Ma, J.; Zhao, Y.; Zhu, W.; Wang, J. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: A systematic review and meta-analysis. Cardiovasc. Diabetol. 2022, 21, 124. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kim, M.K.; Ahn, C.W.; Kang, S.; Nam, J.S.; Kim, K.R.; Park, J.S. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc. Diabetol. 2017, 16, 108. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Tárraga Marcos, P.J.; López-González, Á.A.; Martínez-Almoyna Rifá, E.; Paublini Oliveira, H.; Martorell Sánchez, C.; Tárraga López, P.J.; Ramírez-Manent, J.I. Risk of Insulin Resistance in 44,939 Spanish Healthcare Workers: Association with Sociodemographic Variables and Healthy Habits. Diseases 2025, 13, 33. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hackett, R.A.; Steptoe, A. Type 2 diabetes mellitus and psychological stress—A modifiable risk factor. Nat. Rev. Endocrinol. 2017, 13, 547–560. [Google Scholar] [CrossRef] [PubMed]
- Foguet-Boreu, Q.; Ayerbe García-Morzon, L. Estrés psicosocial, hipertensión arterial y riesgo cardiovascular [Psychosocial stress, high blood pressure and cardiovascular risk]. Hipertens. Riesgo Vasc. 2021, 38, 83–90. (In Spanish) [Google Scholar] [CrossRef] [PubMed]
- Wirtz, P.H.; von Känel, R. Psychological Stress, Inflammation, and Coronary Heart Disease. Curr. Cardiol. Rep. 2017, 19, 111. [Google Scholar] [CrossRef] [PubMed]
- Osborne, M.T.; Shin, L.M.; Mehta, N.N.; Pitman, R.K.; Fayad, Z.A.; Tawakol, A. Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease. Circ. Cardiovasc. Imaging 2020, 13, e010931. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Vaccarino, V.; Bremner, J.D. Stress and cardiovascular disease: An update. Nat. Rev. Cardiol. 2024, 21, 603–616. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Salaroli, L.B.; Cattafesta, M.; Molina, M.D.C.B.; Zandonade, E.; Bissoli, N.S. Insulin resistance and associated factors: A cross-sectional study of bank employees. Clinics 2017, 72, 224–230. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Prajapati, A.K.; Prajapati, R. Prevalence of metabolic syndrome and its risk factors among the government bank’s employees of district Bijnor, Uttar Pradesh: A cross-sectional study. J. Fam. Med. Prim. Care 2024, 13, 5825–5832. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Park, K.; Ahn, C.W.; Lee, S.B.; Kang, S.; Nam, J.S.; Lee, B.K.; Kim, J.H.; Park, J.S. Elevated TyG Index Predicts Progression of Coronary Artery Calcification. Diabetes Care 2019, 42, 1569–1573. [Google Scholar] [CrossRef] [PubMed]
- Luo, H.; Yang, Q.; Xu, H.; Wu, S.; Wang, W.; Zhou, R.; Yang, Y.; Yu, Q. Association between triglyceride-glucose index and the risk of type 2 diabetes mellitus. Arch. Endocrinol. Metab. 2025, 69, e230493. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Moffatt, S.M.; Stewart, D.F.; Jack, K.; Dudar, M.D.; Bode, E.D.; Mathias, K.C.; Smith, D.L. Cardiometabolic health among United States firefighters by age. Prev. Med. Rep. 2021, 23, 101492. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Shan, Z.; Li, Y.; Zong, G.; Guo, Y.; Li, J.; Manson, J.E.; Hu, F.B.; Willett, W.C.; Schernhammer, E.S.; Bhupathiraju, S.N. Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: Results from two large US cohorts of female nurses. BMJ 2018, 363, k4641. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kurniawan, L.B. Triglyceride-Glucose Index As A Biomarker Of Insulin Resistance, Diabetes Mellitus, Metabolic Syndrome, And Cardiovascular Disease: A Review. Ejifcc 2024, 35, 44–51. [Google Scholar] [PubMed] [PubMed Central]
- Sánchez-García, A.; Rodríguez-Gutiérrez, R.; Mancillas-Adame, L.; González-Nava, V.; Díaz González-Colmenero, A.; Solis, R.C.; Álvarez-Villalobos, N.A.; González-González, J.G. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int. J. Endocrinol. 2020, 2020, 4678526. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Camero, A.; Muriel, J.L.; Morell, N.; Lurquin, M.; López González Ángel, A.; Serra-Capó, A.; Villaroel, G. Risk of insulin resistance applying 3 different scales in 703,472 spanish workers: Associated variables. J. Clin. Trials Exp. Investig. 2024, 3, 125–135. [Google Scholar]
- Qiu, J.; He, S.; Yu, C.; Yang, R.; Kuang, M.; Sheng, G.; Zou, Y. Assessing the validity of METS-IR for predicting the future onset of diabetes: An analysis using time-dependent receiver operating characteristics. BMC Endocr. Disord. 2024, 24, 238. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Barchetta, I.; Dule, S.; Bertoccini, L.; Cimini, F.A.; Sentinelli, F.; Bailetti, D.; Marini, G.; Barbonetti, A.; Loche, S.; Cossu, E.; et al. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: A long-term follow-up study. J. Endocrinol. Investig. 2022, 45, 43–51. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Duan, M.; Zhao, X.; Li, S.; Miao, G.; Bai, L.; Zhang, Q.; Yang, W.; Zhao, X. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: Evidence from NHANES 2001–2018. Cardiovasc. Diabetol. 2024, 23, 243. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Balkau, B.; Mhamdi, L.; Oppert, J.M.; Nolan, J.; Golay, A.; Porcellati, F.; Laakso, M.; Ferrannini, E.; on behalf of the EGIR-RISC Study Group. Physical activity and insulin sensitivity: The RISC study. Diabetes 2008, 57, 2613–2618. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hu, F.B.; Li, T.Y.; Colditz, G.A.; Willett, W.C.; Manson, J.E. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003, 289, 1785–1791. [Google Scholar] [CrossRef] [PubMed]
- Helmrich, S.P.; Ragland, D.R.; Leung, R.W.; Paffenbarger, R.S., Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1991, 325, 147–152. [Google Scholar] [CrossRef] [PubMed]
- Mauvais-Jarvis, F. Gender differences in glucose homeostasis and diabetes. Physiol. Behav. 2018, 187, 20–23. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Barros, R.P.; Gustafsson, J.Å. Estrogen receptors and the metabolic network. Cell Metab. 2011, 14, 289–299. [Google Scholar] [CrossRef] [PubMed]
- Lizcano, F.; Guzmán, G. Estrogen Deficiency and the Origin of Obesity during Menopause. BioMed Res. Int. 2014, 2014, 757461. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Karastergiou, K.; Smith, S.R.; Greenberg, A.S.; Fried, S.K. Sex differences in human adipose tissues—The biology of pear shape. Biol. Sex Differ. 2012, 3, 13. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Link, J.C.; Reue, K. Genetic Basis for Sex Differences in Obesity and Lipid Metabolism. Annu. Rev. Nutr. 2017, 37, 225–245. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Regitz-Zagrosek, V.; Kararigas, G. Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol. Rev. 2017, 97, 1–37. [Google Scholar] [CrossRef] [PubMed]
- Cancelliere, C.; Cassidy, J.D.; Ammendolia, C.; Côté, P. Are workplace health promotion programs effective at improving presenteeism in workers? A systematic review and best evidence synthesis of the literature. BMC Public Health 2011, 11, 395. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Proper, K.I.; van Oostrom, S.H. The effectiveness of workplace health promotion interventions on physical and mental health outcomes—A systematic review of reviews. Scand. J. Work Environ. Health 2019, 45, 546–559. [Google Scholar] [CrossRef] [PubMed]
- Conn, V.S.; Hafdahl, A.R.; Cooper, P.S.; Brown, L.M.; Lusk, S.L. Meta-analysis of workplace physical activity interventions. Am. J. Prev. Med. 2009, 37, 330–339. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Knott, C.; Bell, S.; Britton, A. Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. Diabetes Care 2015, 38, 1804–1812. [Google Scholar] [CrossRef] [PubMed]
- Reutrakul, S.; Van Cauter, E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism 2018, 84, 56–66. [Google Scholar] [CrossRef] [PubMed]


| Men n = 34,492 | Women n = 47,528 | ||
|---|---|---|---|
| Variables | Mean (SD) | Mean (SD) | p-Value |
| Age (years) | 40.5 (10.0) | 37.8 (9.1) | <0.001 |
| Height (cm) | 175.4 (6.9) | 162.6 (6.4) | <0.001 |
| Weight (kg) | 82.2 (13.7) | 63.9 (12.3) | <0.001 |
| Waist (cm) | 87.7 (8.9) | 73.0 (7.8) | <0.001 |
| Hip (cm) | 100.3 (8.4) | 95.8 (8.7) | <0.001 |
| SBP (mm Hg) | 123.5 (14.3) | 112.2 (13.6) | <0.001 |
| DBP (mm Hg) | 75.3 (10.4) | 68.2 (9.8) | <0.001 |
| Cholesterol (mg/dL) | 196.4 (37.5) | 192.1 (35.1) | <0.001 |
| HDL-c (mg/dL) | 51.3 (7.1) | 53.9 (7.6) | <0.001 |
| LDL-c (mg/dL) | 120.9 (36.0) | 121.2 (36.0) | <0.001 |
| Triglycerides (mg/dL) | 122.2 (82.3) | 85.5 (46.2) | <0.001 |
| Glucose (mg/dL) | 87.8 (12.5) | 83.5 (10.6) | <0.001 |
| Variables | n (%) | n (%) | p-Value |
| 18–29 years | 5152 (14.9) | 9464 (19.9) | <0.001 |
| 30–39 years | 11,728 (34.0) | 19,296 (40.6) | |
| 40–49 years | 10,564 (30.6) | 13,360 (28.1) | |
| 50–59 years | 5880 (17.1) | 4664 (9.8) | |
| 60–69 years | 1168 (3.4) | 744 (1.6) | |
| Smokers | 9288 (26.9) | 13,856 (29.2) | <0.001 |
| Yes physical activity | 16,352 (47.4) | 28,200 (59.3) | <0.001 |
| Yes Mediterranean diet | 14,640 (42.4) | 27,648 (58.2) | <0.001 |
| TyG Index | METS-IR | SPISE-IR | ||
|---|---|---|---|---|
| Men | n | Mean (SD) | Mean (SD) | Mean (SD) |
| 20–29 years | 5152 | 8.1 (0.5) | 35.1 (6.8) | 1.4 (0.4) |
| 30–39 years | 11,728 | 8.3 (0.5) | 37.3 (6.6) | 1.6 (0.4) |
| 40–49 years | 10,564 | 8.5 (0.6) | 39.8 (7.4) | 1.7 (0.5) |
| 50–59 years | 5880 | 8.6 (0.6) | 41.9 (6.4) | 1.9 (0.5) |
| 60–69 years | 1168 | 8.7 (0.5) | 42.0 (7.4) | 1.9 (0.4) |
| Non-Smokers | 25,204 | 8.4 (0.6) | 38.6 (7.1) | 1.6 (0.5) |
| Smokers | 9288 | 8.5 (0.6) | 38.9 (8.1) | 1.7 (0.5) |
| Yes Mediterranean diet | 14,640 | 8.1 (0.4) | 33.6 (3.4) | 1.4 (0.2) |
| Non Mediterranean diet | 19,852 | 8.7 (0.6) | 42.5 (7.3) | 1.9 (0.5) |
| Yes Physical activity | 16,352 | 8.1 (0.4) | 33.6 (3.3) | 1.4 (0.2) |
| Non Physical activity | 18,140 | 8.7 (0.6) | 43.3 (7.0) | 2.0 (0.5) |
| Women | n | % | % | % |
| 20–29 years | 9464 | 8.0 (0.5) | 32.1 (6.6) | 1.3 (0.4) |
| 30–39 years | 19,296 | 8.0 (0.4) | 33.0 (7.0) | 1.3 (0.4) |
| 40–49 years | 13,360 | 8.1 (0.5) | 34.4 (7.1) | 1.4 (0.4) |
| 50–59 years | 4664 | 8.3 (0.5) | 36.6 (6.9) | 1.5 (0.4) |
| 60–69 years | 744 | 8.4 (0.4) | 38.1 (6.9) | 1.6 (0.4) |
| Non-Smokers | 33,672 | 8.0 (0.5) | 33.3 (7.0) | 1.4 (0.4) |
| Smokers | 13,856 | 8.1 (0.5) | 33.8 (7.1) | 1.4 (0.4) |
| Yes Mediterranean diet | 27,648 | 7.9 (0.4) | 30.2 (3.6) | 1.2 (0.2) |
| Non Mediterranean diet | 19,880 | 8.3 (0.5) | 38.4 (8.0) | 1.7 (0.5) |
| Yes Physical activity | 28,200 | 7.9 (0.4) | 29.9 (3.4) | 1.2 (0.2) |
| Non Physical activity | 19,328 | 8.3 (0.5) | 39.0 (7.6) | 1.7 (0.5) |
| TyG Index High | METS-IR High | SPISE-IR High | ||
|---|---|---|---|---|
| Men | n | % | % | % |
| 20–29 years | 5152 | 10.1 | 4.7 | 6.8 |
| 30–39 years | 11,728 | 18.5 | 4.6 | 8.3 |
| 40–49 years | 10,564 | 28.0 | 8.8 | 15.1 |
| 50–59 years | 5880 | 34.8 | 10.3 | 16.4 |
| 60–69 years | 1168 | 39.0 | 12.9 | 21.0 |
| Non-Smokers | 25,204 | 21.2 | 7.0 | 12.3 |
| Smokers | 9288 | 30.2 | 8.8 | 13.4 |
| Yes Mediterranean diet | 14,640 | 2.2 | 2.1 | 3.1 |
| Non Mediterranean diet | 19,852 | 39.5 | 9.6 | 18.2 |
| Yes Physical activity | 16,352 | 1.9 | 1.8 | 2.5 |
| Non Physical activity | 18,140 | 43.2 | 11.0 | 20.2 |
| Women | n | % | % | % |
| 20–29 years | 9464 | 7.0 | 2.7 | 3.6 |
| 30–39 years | 19,296 | 7.3 | 3.4 | 4.7 |
| 40–49 years | 13,360 | 9.5 | 4.2 | 6.0 |
| 50–59 years | 4664 | 19.2 | 5.5 | 7.8 |
| 60–69 years | 744 | 31.2 | 6.5 | 10.8 |
| Non-Smokers | 33,672 | 8.8 | 3.1 | 4.9 |
| Smokers | 13,856 | 10.7 | 4.0 | 5.4 |
| Yes Mediterranean diet | 27,648 | 1.1 | 1.5 | 2.1 |
| Non Mediterranean diet | 19,880 | 21.0 | 7.0 | 10.3 |
| Yes Physical activity | 28,200 | 0.6 | 1.2 | 1.5 |
| Non Physical activity | 19,328 | 22.5 | 8.0 | 11.6 |
| Variable | TyG OR (95% CI) | TyG ARD % (95% CI) | METS-IR OR (95% CI) | METS-IR ARD % (95% CI) | SPISE-IR OR (95% CI) | SPISE-IR ARD % (95% CI) |
|---|---|---|---|---|---|---|
| Women | 1 (ref.) | — | 1 (ref.) | — | 1 (ref.) | — |
| Men | 2.48 (2.37–2.60) | +11.6 (10.9–12.3) | 1.47 (1.38–1.57) | +3.1 (2.6–3.6) | 1.88 (1.78–1.99) | +5.7 (5.2–6.2) |
| 30–39 years | 1.29 (1.22–1.36) | +4.0 (3.4–4.6) | 1.13 (1.10–1.17) | +1.3 (0.9–1.7) | 1.14 (1.10–1.18) | +1.7 (1.3–2.1) |
| 40–49 years | 1.62 (1.51–1.73) | +8.5 (7.7–9.3) | 1.28 (1.22–1.35) | +2.4 (1.9–2.9) | 1.39 (1.28–1.50) | +3.8 (3.2–4.4) |
| Smokers | 1.62 (1.54–1.70) | +9.0 (8.3–9.7) | 1.18 (1.13–1.24) | +2.0 (1.6–2.4) | 1.14 (1.09–1.19) | +1.1 (0.8–1.4) |
| No Mediterranean diet | 2.35 (2.10–2.61) | +12.3 (11.1–13.5) | 4.12 (3.21–5.03) | +4.8 (4.1–5.5) | 5.62 (4.50–6.75) | +8.2 (7.1–9.3) |
| No Physical activity | 4.59 (3.98–5.19) | +19.7 (18.5–20.9) | 7.42 (5.99–8.86) | +6.4 (5.6–7.2) | 8.49 (6.51–10.48) | +9.9 (8.7–11.1) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ramírez Gallegos, A.; Tárraga López, P.J.; López-González, Á.A.; Busquets-Cortés, C.; Coll Campayo, I.; García Samuelsson, M.; Ramírez Manent, J.I. Prevalence of Elevated Insulin Resistance Risk in a Large Office Worker Population: Sex-Stratified Analyses and Lifestyle Correlates. Diabetology 2025, 6, 137. https://doi.org/10.3390/diabetology6110137
Ramírez Gallegos A, Tárraga López PJ, López-González ÁA, Busquets-Cortés C, Coll Campayo I, García Samuelsson M, Ramírez Manent JI. Prevalence of Elevated Insulin Resistance Risk in a Large Office Worker Population: Sex-Stratified Analyses and Lifestyle Correlates. Diabetology. 2025; 6(11):137. https://doi.org/10.3390/diabetology6110137
Chicago/Turabian StyleRamírez Gallegos, Alberto, Pedro Juan Tárraga López, Ángel Arturo López-González, Carla Busquets-Cortés, Irene Coll Campayo, Miguel García Samuelsson, and José Ignacio Ramírez Manent. 2025. "Prevalence of Elevated Insulin Resistance Risk in a Large Office Worker Population: Sex-Stratified Analyses and Lifestyle Correlates" Diabetology 6, no. 11: 137. https://doi.org/10.3390/diabetology6110137
APA StyleRamírez Gallegos, A., Tárraga López, P. J., López-González, Á. A., Busquets-Cortés, C., Coll Campayo, I., García Samuelsson, M., & Ramírez Manent, J. I. (2025). Prevalence of Elevated Insulin Resistance Risk in a Large Office Worker Population: Sex-Stratified Analyses and Lifestyle Correlates. Diabetology, 6(11), 137. https://doi.org/10.3390/diabetology6110137

